Targeting BARD1 slows PDAC growth in vitro and in vivo and sensitizes cells to DNA damaging agents

被引：0
|
作者：
Patel, Sohum
Arkala, Anoohya
Nevler, Avinoam
Coats, Carolyn
Yeo, Charles J.
Jain, Aditi
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6102
引用
收藏
页数：2
相关论文
共 50 条
  • [21] An isoform of BARD1, associated with many types of cancer, is a driver of oncogenesis by inducing telomere aberrations in vitro and in vivo
    Pilyugin, Maxim
    Andre, Pierre-Alain
    Ratajska, Magdalena
    Irminger-Finger, Irmgard
    CANCER RESEARCH, 2015, 75
  • [22] Poly(ADP-ribose) Glycohydrolase Deficiency Sensitizes Mouse ES Cells to DNA Damaging Agents
    Fujihara, H.
    Ogino, H.
    Maeda, D.
    Shirai, H.
    Nozaki, T.
    Kamada, N.
    Jishage, K.
    Tanuma, S.
    Takato, T.
    Ochiya, T.
    Sugimura, T.
    Masutani, M.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (08) : 953 - 962
  • [23] USP25 inhibits DNA damage by stabilizing BARD1 protein in a house dust mite-induced asthmatic model in vitro and in vivo
    Gan, Cong
    Wang, Ye
    Zhao, Qian
    Kong, Mi
    Chen, Jinnan
    Zhang, Wanying
    Tan, Lingxiao
    Tian, Man
    CELL BIOLOGY INTERNATIONAL, 2022, 46 (06) : 922 - 932
  • [24] Pharmacological targeting of differential DNA repair, radio-sensitizes WRN-deficient cancer cells in vitro and in vivo
    Gupta, Pooja
    Saha, Bhaskar
    Chattopadhyay, Subrata
    Patro, Birija Sankar
    BIOCHEMICAL PHARMACOLOGY, 2021, 186
  • [25] A rationally designed peptide enhances homologous recombination in vitro and resistance to DNA damaging agents in vivo
    Chen, Li-Tzu
    Wang, Andrew H. -J.
    NUCLEIC ACIDS RESEARCH, 2010, 38 (13) : 4361 - 4371
  • [26] Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA-Damaging Agents: Implications for Oncolytic Virus Therapy
    Fox, Candace R.
    Parks, Griffith D.
    JOURNAL OF VIROLOGY, 2018, 92 (07)
  • [27] Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways
    Conte, Damiano
    Huh, Michael
    Goodall, Emma
    Delorme, Marilyne
    Parks, Robin J.
    Picketts, David J.
    PLOS ONE, 2012, 7 (12):
  • [28] A Src/Abl kinase inhibitor, bosutinib, downregulates and inhibits PARP enzyme and sensitizes cells to the DNA damaging agents
    Kirmizibayrak, Petek Ballar
    Ilhan, Recep
    Yilmaz, Sinem
    Gunal, Selin
    Tepedelen, Burcu Erbaykent
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2018, 43 (02): : 101 - 109
  • [29] Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
    Broustas, Constantinos G.
    Duval, Axel J.
    Chaudhary, Kunal R.
    Friedman, Richard A.
    Virk, Renu K.
    Lieberman, Howard B.
    ONCOGENE, 2020, 39 (12) : 2467 - 2477
  • [30] Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents
    Constantinos G. Broustas
    Axel J. Duval
    Kunal R. Chaudhary
    Richard A. Friedman
    Renu K. Virk
    Howard B. Lieberman
    Oncogene, 2020, 39 : 2467 - 2477
12345